Pharmacogenetics of asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 165, Issue 7, 2002, Pages 861-866

  Palmer, Lyle J ^a,b,c   Silverman, Eric S ^a,b,c   Weiss, Scott T ^a,b,c   Drazen, Jeffrey M ^a,b,c  

^a CHANNING LABORATORY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRELEUTON; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; SALBUTAMOL; ZAFIRLUKAST;

ASTHMA; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; HUMAN; PHARMACOGENETICS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0036528923     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.165.7.2109096     Document Type: Review

References (50)

1. The health economics of asthma and rhinitis. I. Assessing the economic impact
2. Genomic approaches to understanding asthma
3. Pharmacogenetics of asthma
4. Heterogeneity of therapeutic responses in asthma
5. Genetic control of isoniazid metabolism in man
6. A general approach to single-nucleotide polymorphism discovery
7. Single nucleotide polymorphisms as tools in human genetics
8. Using single nucleotide polymorphisms (SNPs) as a means to understanding the pathophysiology of asthma
9. New goals for the US Human Genome Project: 1998-2003
10. Single nucleotide polymorphisms and the future of genetic epidemiology
11. The essence of SNPs
12. Atopy and asthma
13. Treatment of acute asthma: A new look at the old and at the new
14. 2-adrenergic receptors in airway smooth muscle alters myocyte function and ablates bronchial hyperreactivity
15. 2-adrenergic receptor on the response to regular use of albuterol in asthma
16. Pharmacogenetics of β-1- and β-2-adrenergic receptors
17. 2-adrenergic receptors: Relevance to asthma
18. 2-Adrenoreceptor polymorphisms are in linkage disequilibrium but are not associated with asthma in an adult population
19. 2-adrenergic receptor regulate receptor expression
20. 2-adrenergic receptor impart distinct agonist-promoted regulatory properties
21. 2-adrenergic receptor in normal and asthmatic subjects
22. 2-adrenoceptor (ADRB2) haplotypes. A population study
23. Atopy and asthma genes: Where do we stand?
24. 2-agonist therapy in asthma
25. 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics
26. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma
27. 2-adrenergic receptor on response to regular use of albuterol in asthma
28. 2-adrenoceptor and response to albuterol in children with and without a history of wheezing
29. 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness
30. Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects
31. Leukotriene antagonists and synthesis inhibitors: New directions in asthma therapy
32. Treatment of asthma with drugs modifying the leukotriene pathway
33. Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription
34. Egr-1 and Sp1 interact functionally with the 5-lipoxygenase promoter and its naturally occurring mutants
35. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment
36. 4 synthase on the clinical response to zafirlukast and fluticasone
37. Leukotriene C-4 synthase: A pivotal enzyme in the biosynthesis of the cysteinyl leukotrienes
38. 4 synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast
39. 4 synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma
40. Searching for genetic determinants in the new millennium
41. Case-control association studies for the genetics of complex respiratory diseases
42. Major factors influencing linkage disequilibrium by analysis of different chromosome regions in distinct populations: Demography, chromosome recombination frequency and selection
43. Linkage disequilibrium patterns vary with chromosomal location: A case study from the von Willebrand factor region
44. Linkage disequilibrium predicts physical distance in the adenomatous polyposis coli region
45. The transmission/disequilibrium test: History, subdivision, and admixture
46. Use of unlinked genetic markers to detect population stratification in association studies
47. Association mapping in structured populations
48. Detecting association in a case-control study while correcting for population stratification
49. The power of association studies to detect the contribution of candidate genetic loci to variation in complex trails